Anderson Clark - Concepedia

Author

Anderson Clark

Ono Pharmaceutical (United States)ORCID

Also Known As

A. Clark, Anderson Clark, Anderson Clark2

Publications

242

Citations

H-Index

Concepts

All Affiliations

Ono Pharmaceutical (United States)Research & Development Institute

About

Anderson Clark is an author at Ono Pharmaceutical (United States) specializing in medicine, radiation oncology, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	145
2	Cell Biology	2	2	76
3	Social Sciences	1	1	24
4	Biochemistry	1	1	29
5	Chemical Biology	1	1	16

Anderson Clark

Publications

181

Citations

H-Index

Page 1

	Year	Citations
Inhibiting Aurora Kinases Reduces Tumor Growth and Suppresses Tumor Recurrence after Chemotherapy in Patient-Derived Triple-Negative Breast Cancer Xenografts Angela Romanelli, Anderson Clark, Franck Assayag, Molecular Cancer Therapeutics Breast OncologyMedicineReceptor Tyrosine KinaseTnbc Cell LinesSuppresses Tumor Recurrence	2012	45
M2698 is a potent dual-inhibitor of p70S6K and Akt that affects tumor growth in mouse models of cancer and crosses the blood-brain barrier. Andreas Machl, Erik Wilker, Hui Tian, PubMed Chemoprevention StrategyPotent Dual-inhibitorCancer BiologyGliomaTumor Biology	2016	31
Synthesis, evaluation, and metabolism of novel [6]-shogaol derivatives as potent Nrf2 activators Yingdong Zhu, Pei Wang, Yantao Zhao, Free Radical Biology and Medicine BiochemistryMedicinePotent Nrf2 ActivatorsPharmacologyPharmaceutical Chemistry	2016	29
Brain penetration and efficacy of tepotinib in orthotopic patient-derived xenograft models of MET-driven non-small cell lung cancer brain metastases Manja Friese‐Hamim, Anderson Clark, Dominique Perrin, Lung Cancer	2021	25
LGBT Assisted Reproduction: Current Practice and Future Possibilities A. Evan Eyler, Samuel C. Pang, Anderson Clark LGBT Health Lgbt Assisted ReproductionInfertilityGender StudiesHomosexualityQueer Theory	2014	24
SAR and evaluation of novel 5H-benzo[c][1,8]naphthyridin-6-one analogs as Aurora kinase inhibitors Srinivasa Karra, Yufang Xiao, Xiaoling Chen, Bioorganic & Medicinal Chemistry Letters Pharmaceutical ChemistryMedicineAnti-cancer AgentChemical BiologyPharmacology	2013	16
Identification of Clinical Candidate M2698, a Dual p70S6K and Akt Inhibitor, for Treatment of PAM Pathway-Altered Cancers Lizbeth DeSelm, Bayard R. Huck, Ruoxi Lan, Journal of Medicinal Chemistry	2021	11

Page 1